104 related articles for article (PubMed ID: 29317049)
1. Autoimmunity against a glycolytic enzyme as a possible cause for persistent symptoms in Lyme disease.
Maccallini P; Bonin S; Trevisan G
Med Hypotheses; 2018 Jan; 110():1-8. PubMed ID: 29317049
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease.
Pozsgay V; Kubler-Kielb J; Coxon B; Marques A; Robbins JB; Schneerson R
Carbohydr Res; 2011 Sep; 346(12):1551-63. PubMed ID: 21601180
[TBL] [Abstract][Full Text] [Related]
3. Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis.
Miklossy J; Kasas S; Zurn AD; McCall S; Yu S; McGeer PL
J Neuroinflammation; 2008 Sep; 5():40. PubMed ID: 18817547
[TBL] [Abstract][Full Text] [Related]
4. Borrelia burgdorferi enolase is a surface-exposed plasminogen binding protein.
Floden AM; Watt JA; Brissette CA
PLoS One; 2011; 6(11):e27502. PubMed ID: 22087329
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome.
Fitzgerald BL; Graham B; Delorey MJ; Pegalajar-Jurado A; Islam MN; Wormser GP; Aucott JN; Rebman AW; Soloski MJ; Belisle JT; Molins CR
Clin Infect Dis; 2021 Oct; 73(7):e2342-e2349. PubMed ID: 32975577
[TBL] [Abstract][Full Text] [Related]
6. Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data.
Chung MK; Caboni M; Strandwitz P; D'Onofrio A; Lewis K; Patel CJ
EBioMedicine; 2023 Apr; 90():104524. PubMed ID: 36958992
[TBL] [Abstract][Full Text] [Related]
7. Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?
Adler BL; Chung T; Rowe PC; Aucott J
Front Neurol; 2024; 15():1344862. PubMed ID: 38390594
[TBL] [Abstract][Full Text] [Related]
8. Lyme disease and the pursuit of a clinical cure.
Adkison H; Embers ME
Front Med (Lausanne); 2023; 10():1183344. PubMed ID: 37293310
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Possible Link between Interferon-α and Lyme Disease.
Alaedini A; Crow MK; Fallon BA; Jacek E; Wormser GP
Emerg Infect Dis; 2023 Nov; 29(11):2409. PubMed ID: 37877556
[No Abstract] [Full Text] [Related]
10. Epitopes of Immunoreactive Proteins of
Dobrut A; Brzozowska E; Górska S; Pyclik M; Gamian A; Bulanda M; Majewska E; Brzychczy-Włoch M
Front Cell Infect Microbiol; 2018; 8():349. PubMed ID: 30333963
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in post-treatment Lyme disease and association with clinical symptoms.
Keshtkarjahromi M; Rebman AW; Antar AAR; Manabe YC; Gutierrez-Alamillo L; Casciola-Rosen LA; Aucott JN; Miller JB
Clin Exp Rheumatol; 2024 Apr; ():. PubMed ID: 38607687
[TBL] [Abstract][Full Text] [Related]
12. Empirical validation of the Horowitz Multiple Systemic Infectious Disease Syndrome Questionnaire for suspected Lyme disease.
Citera M; Freeman PR; Horowitz RI
Int J Gen Med; 2017; 10():249-273. PubMed ID: 28919803
[TBL] [Abstract][Full Text] [Related]
13. Post-Treatment Lyme Disease Syndrome: Need for Diagnosis and Treatment.
Maksimyan S; Syed MS; Soti V
Cureus; 2021 Oct; 13(10):e18703. PubMed ID: 34659931
[TBL] [Abstract][Full Text] [Related]
14. Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review.
Horowitz RI; Fallon J; Freeman PR
Microorganisms; 2024 Apr; 12(5):. PubMed ID: 38792737
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional roles of γ-enolase in the central nervous system: more than a neuronal marker.
Horvat S; Kos J; Pišlar A
Cell Biosci; 2024 May; 14(1):61. PubMed ID: 38735971
[TBL] [Abstract][Full Text] [Related]
16. IL-10 Deficiency Reveals a Role for TLR2-Dependent Bystander Activation of T Cells in Lyme Arthritis.
Whiteside SK; Snook JP; Ma Y; Sonderegger FL; Fisher C; Petersen C; Zachary JF; Round JL; Williams MA; Weis JJ
J Immunol; 2018 Feb; 200(4):1457-1470. PubMed ID: 29330323
[TBL] [Abstract][Full Text] [Related]
17. Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy.
Eckman EA; Pacheco-Quinto J; Herdt AR; Halperin JJ
Clin Infect Dis; 2018 Jun; 67(1):80-88. PubMed ID: 29340592
[TBL] [Abstract][Full Text] [Related]
18. Promising alternatives for one-tier testing of Lyme borreliosis.
Alasel M; Keusgen M
Clin Chim Acta; 2018 Apr; 479():148-154. PubMed ID: 29366833
[TBL] [Abstract][Full Text] [Related]
19. An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the Netherlands.
van Gorkom T; Sankatsing SUC; Voet W; Ismail DM; Muilwijk RH; Salomons M; Vlaminckx BJM; Bossink AWJ; Notermans DW; Bouwman JJM; Kremer K; Thijsen SFT
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367297
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
